A meta-analysis of randomized controlled trials evaluating the efficacy of epinephrine for the treatment of acute viral bronchiolitis

Archives of Pediatrics and Adolescent Medicine

Volumn 157, Issue 10, 2003, Pages 957-964

  Hartling, Lisa ^a   Wiebe, Natasha ^a   Russell, Kelly ^a   Patel, Hema ^b   Klassen, Terry P ^a,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; PLACEBO; SALBUTAMOL; SALBUTAMOL SULFATE;

ACUTE DISEASE; BREATHING RATE; BRONCHIOLITIS; BRONCHODILATATION; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG INDICATION; EMBASE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEDLINE; META ANALYSIS; OUTPATIENT; OXYGEN SATURATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCORING SYSTEM; STANDARDIZATION; STATISTICAL SIGNIFICANCE; VIRUS INFECTION;

ACUTE DISEASE; ALBUTEROL; BRONCHIOLITIS, VIRAL; BRONCHODILATOR AGENTS; CHILD WELFARE; CHILD, PRESCHOOL; EPINEPHRINE; HUMANS; INFANT; INFANT WELFARE; TREATMENT OUTCOME;

EID: 0141484525     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.157.10.957     Document Type: Review

References (28)

1. Klassen TP. Recent advances in the treatment of bronchiolitis and laryngitis. Pediatr Clin North Am. 1997;44:249-261.
2. Everard ML. Bronchiolitis: origins and optimal management. Drugs. 1995;49:885-896.
3. 2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics. 1997;100:233-239.
4. Kellner JD, Ohlsson A, Gadomski AM, Wang EEL. Bronchodilators for bronchiolitis [Cochrane Review on CD-ROM]. Issue 2. Oxford, England: Cochrane Library, Update Software; 2000.
5. Wohl MEB, Chernick V. State of the art: bronchiolitis. Am Rev Respir Dis. 1978;118:759-781.
6. Mull CC, Scarfone RJ, Ferri LR, et al. Nebulized epinephrine in the emergency department treatment of bronchiolitis [abstract]. Pediatr Res. 2002;51:100.
7. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.
8. Schulz KF, Chalmers L, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-412.
9. Lowell DI, Lister G, Von Koss H, McCarthy P. Wheezing in infants: the response to epinephrine. Pediatrics. 1987;79:939-945.
10. Okutan V, Akin R, Kurekci AE, Yanik A, Ozcan O, Gokcay E. Effectiveness of nebulised adrenaline and salbutamol in the treatment of infants with bronchiolitis. Bull Gulhane Milit Med Acad 1998;40:199-204.
11. Abul-Ainine A, Luyt D. Short term effects of adrenaline in bronchiolitis [in Turkish]: a randomised controlled trial. Arch Dis Child. 2002;86:276-279.
12. Hariprakash S, Alexander J, Carroll W, et al. Randomized controlled trial of nebulized adrenaline in acute bronchiolitis. Pedietr Allergy Immunol. 2003;14:134-139.
13. Reijonen T, Korppi M, Pitkäkangas S, Tenhola S, Remes K. The clinical efficacy of nebulized racemic epinephrine and albuterol in acute bronchiolitis. Arch Pediatr Adolesc Med. 1995;149:686-692.
14. Sanchez I, De Koster J, Powell RE, Wolstein R, Chernick V. Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics in infants with bronchiolitis. J Pediatr, 1993;122:145-151.
15. Kristánsson S, Lødrup Carlsen KC, Wennergren G, Strannegård I-L, Carlsen K-H. Nebulised racemic adrenaline in the treatment of acute bronchiolitis in infants and toddlers. Arch Dis Child. 1993;69:650-654.
16. Wainwright C, Altamirano L, Cheney M, et al. A multi-centre randomised controlled double blind trial of nobulised adrenaline in infants with bronchiolitis. N Engl J Med. 2003;349:27-35.
17. Bertrand P, Aranibar H, Castro E, Sánchez I. Efficacy of nebulized epinephrine versus salbutamol in hospitalised infants with bronchiolitis. Pediatr Pulmonol. 2001;31:284-288.
18. Normand S-LT. Tutorial in biostatistics meta-analysis: formulating, evaluating, combining, and reporting. Stat Med. 1999;18:321-359.
19. Clarke M, Oxman AD, eds. Cochrane reviewers' handbook [updated June 2000]. In: Review Manager [computer program]. Version 4.1. Oxford, England: Cochrane Collaboration; 2000.
20. Hartling L, Wiebe N, Russell KF, Patel H, Klassen TP. Epinephrine for the treatment of acute viral bronchiolitis: a systematic review [abstract]. PediatrRes. 2002;51:86.
21. Barlas C, Kiper N, Gocmen A, et al. Racemic adrenaline and other treatment regiments in mild and moderate bronchiolitis [in Turkish]. Cocuk Sagligi Ve Hastaliklari Dergisi. 1998;41:155-165.
22. Menon K, Sutcliffe T, Klassen TP. A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. J Pediatr. 1995;126:1004-1007.
23. Ray MS, Singh V. Comparison of nebulized adrenaline versus salbutamol in wheeze associated respiratory tract infection in infants. Indian Pediatr. 2002;39:12-22.
24. Patel H, Platt RW, Pekeles GS, Ducharme F. A randomized, controlled trial of the effectiveness of nebulized therapy with epinephrine compared with albuterol and saline in infants hospitalized for acute viral bronchiolitis. J Pediatr. 2002;141:818-824.
25. Tal A, Bavilski C, Yohai D, Bearman JE, Gorodischer R, Moses SW. Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics. 1983;71:13-18.
26. Allen LH. The role of nutrition in the onset and treatment of metabolic bone disease. Nutr Update. 1983;1:263-281.
27. Bierman CW, Pierson WE. The pharmacologic management of status asthmaticus in children. Pediatrics. 1974;54:245-247.
28. Colditz GA, Miller JN, Mosteller F. How study design affects outcomes in comparisons of therapy, I: medical. Stat Med. 1989;8:441-454.